Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer

被引:25
作者
Park, Yae Won [1 ,2 ,3 ]
An, Chansik [4 ]
Lee, JaeSeong [5 ]
Han, Kyunghwa [1 ,2 ,3 ]
Choi, Dongmin [6 ]
Ahn, Sung Soo [1 ,2 ,3 ]
Kim, Hwiyoung [1 ,2 ,3 ]
Ahn, Sung Jun [7 ]
Chang, Jong Hee [8 ]
Kim, Se Hoon [9 ]
Lee, Seung-Koo [1 ,2 ,3 ]
机构
[1] Yonsei Univ, Coll Med, Dept Radiol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Res Inst Radiol Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Ctr Clin Imaging Data Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea
[4] Natl Hlth Insurance Serv Ilsan Hosp, Res & Anal Team, Goyang, South Korea
[5] Yonsei Univ, Dept Mech Engn, Seoul, South Korea
[6] Yonsei Univ, Dept Comp Sci, Seoul, South Korea
[7] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea
[8] Yonsei Univ, Dept Neurosurg, Coll Med, Seoul, South Korea
[9] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Epidermal growth factor receptor; Imaging; Diffusion tensor; Machine learning; Magnetic resonance imaging; Radiomics; TUMORS; FEATURES; PROGRESSION; DIAGNOSIS; SURVIVAL; TEXTURE; LESIONS; GENE;
D O I
10.1007/s00234-020-02529-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose To assess whether the radiomic features of diffusion tensor imaging (DTI) and conventional postcontrast T1-weighted (T1C) images can differentiate the epidermal growth factor receptor (EGFR) mutation status in brain metastases from non-small cell lung cancer (NSCLC). Methods A total of 99 brain metastases in 51 patients who underwent surgery or biopsy with underlying NSCLC and known EGFR mutation statuses (57 from EGFR wild type, 42 from EGFR mutant) were allocated to the training (57 lesions in 31 patients) and test (42 lesions in 20 patients) sets. Radiomic features (n= 526) were extracted from preoperative MR images including T1C and DTI. Radiomics classifiers were constructed by combinations of five feature selectors and four machine learning algorithms. The trained classifiers were validated on the test set, and the classifier performance was assessed by determining the area under the curve (AUC). Results EGFR mutation status showed an overall discordance rate of 12% between the primary tumors and corresponding brain metastases. The best performing classifier was a combination of the tree-based feature selection and linear discriminant algorithm and 5 features were selected (1 from ADC, 2 from fractional anisotropy, and 2 from T1C images), resulting in an AUC, accuracy, sensitivity, and specificity of 0.73, 78.6%, 81.3%, and 76.9% in the test set, respectively. Conclusions Radiomics classifiers integrating multiparametric MRI parameters may have potential in differentiating the EGFR mutation status in brain metastases from NSCLC.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 50 条
  • [41] MRI features and whole-lesion apparent diffusion coefficient histogram analysis of brain metastasis from non-small cell lung cancer for differentiating epidermal growth factor receptor mutation status
    Zheng, Y.
    Huang, W. -J.
    Han, N.
    Jiang, Y. -l.
    Ma, L. -Y.
    Zhang, J.
    CLINICAL RADIOLOGY, 2023, 78 (03) : E243 - E250
  • [42] Dynamic Contrast-enhanced MR Imaging Parameters in Bone Metastases from Non-Small Cell Lung Cancer: Comparison between Lesions with and Lesions without Epidermal Growth Factor Receptor Mutation in Primary Lung Cancer
    Kim, Hyun Su
    Yoon, Young Cheol
    Kwon, Soyi
    Lee, Ji Hyun
    Ahn, Soohyun
    Ahn, Hyeon Seon
    RADIOLOGY, 2017, 284 (03) : 815 - 823
  • [43] The number of brain metastases predicts the survival of non-small cell lung cancer patients with EGFR mutation status
    Shao, Jun
    Li, Jingwei
    Song, Lujia
    He, Qiuyao
    Wu, Yuxuan
    Li, Linhui
    Liu, Dan
    Wang, Chengdi
    Li, Weimin
    CANCER REPORTS, 2022, 5 (09)
  • [44] Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer
    Li, Lina
    Luo, Shuimei
    Lin, Heng
    Yang, Haitao
    Chen, Huijuan
    Liao, Ziyuan
    Lin, Wanzun
    Zheng, Weili
    Xie, Xianhe
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2510 - 2520
  • [45] Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: a post-mortem study
    Watzka, Stefan B.
    Rauscher-Poetsch, Irene
    Nierlich, Patrick
    Setinek, Ulrike
    Koestler, Wolfgang J.
    Poetschger, Ulrike
    Mueller, Michael R.
    Attems, Johannes
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 38 (01) : 34 - 37
  • [46] Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer
    Jakobsen, Jan Nyrop
    Santoni-Rugiu, Eric
    Sorensen, Jens Benn
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 131 - 137
  • [47] Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden
    Fernandes, Ancilla W.
    Wu, Bingcao
    Turner, Ralph M.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (11) : 1136 - 1147
  • [48] MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors
    Qu, J.
    Zhang, T.
    Zhang, X.
    Zhang, W.
    Li, Y.
    Gong, Q.
    Yao, L.
    Lui, S.
    CLINICAL RADIOLOGY, 2024, 79 (04) : e582 - e591
  • [49] Clinical significance of epidermal growth factor receptor mutations in resected stage IA non-small cell lung cancer
    Tsai, Yuan-Ming
    Lin, Kuan-Hsun
    Kuo, Yen-Shou
    Lin, Yu-Chieh
    Chien, Yu-Hsin
    Chou, Hsiu-Ping
    Chen, Ying-Yi
    Huang, Hsu-Kai
    Wu, Ti-Hui
    Chang, Hung
    Lee, Shih-Chun
    Huang, Tsai-Wang
    FORMOSAN JOURNAL OF SURGERY, 2022, 55 (03) : 109 - 115
  • [50] Epidermal growth factor receptor somatic mutation analysis in 354 Chinese patients with non-small cell lung cancer
    Quan, Xueping
    Gao, Hongjun
    Wang, Zhikuan
    Li, Jie
    Zhao, Wentao
    Liang, Wei
    Yu, Qiang
    Guo, Dongliang
    Hao, Zhanping
    Liu, Jingxin
    ONCOLOGY LETTERS, 2018, 15 (02) : 2131 - 2138